# Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study

> **NCT06450171** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 1000 (estimated)

## Conditions studied

- Cancer Predisposition Syndrome
- Predisposition, Genetic

## Interventions

- **OTHER:** GRAIL Galleri Test

## Key facts

- **NCT ID:** NCT06450171
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-27
- **Primary completion:** 2027-01-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06450171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06450171, "Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06450171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*